OTCMKTS:YECO EV Biologics (YECO) Stock Price, News & Analysis $0.26 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.26▼$0.2650-Day Range$0.26▼$0.5752-Week Range$0.26▼$1.95VolumeN/AAverage Volume231 shsMarket Capitalization$2.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get EV Biologics alerts: Email Address Ad Monument Traders AllianceThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.See here to see the full details. About EV Biologics Stock (OTCMKTS:YECO)EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.Read More YECO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YECO Stock News HeadlinesJuly 25 at 1:48 PM | forbes.comBest EV Stocks Of 2024July 20, 2024 | forbes.comChina Biologic ProductsJuly 26, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.May 29, 2024 | investopedia.comHow Much Does It Cost to Charge an EV on a Road Trip?May 1, 2024 | seekingalpha.comWXIBF WuXi Biologics (Cayman) Inc.March 22, 2024 | morningstar.comNurExone Biologic Inc NRXBFFebruary 21, 2024 | usatoday.comBest EV stocks in February 2024January 24, 2024 | finance.yahoo.comSoft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and CompaniesJuly 26, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.January 24, 2024 | finance.yahoo.comFill Finish Manufacturing Market Forecast Report - A US$ 17.165 Billion Market by 2030, Amplified by Rising Demand for Prefilled SyringesDecember 15, 2023 | uk.investing.comY Biologics Inc (338840)October 17, 2023 | reuters.comChinese EV startup WM Motor files for pre-restructuringOctober 4, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Funding and SalesOctober 2, 2023 | finance.yahoo.comEV Biologics Updates on Funding and SalesAugust 16, 2023 | finance.yahoo.comEV Biologics Completes Production of Cutting-Edge MSC Exosome-Based TherapeuticAugust 7, 2023 | finance.yahoo.comEV Biologics Appoints Senior Investment Banker as Corporate Finance DirectorAugust 3, 2023 | money.usnews.comHow the New EV Tax Credit Will Affect Your Auto LoanAugust 2, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Hires Senior Chief Financial OfficerSee More Headlines Receive YECO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConstruction Industry Concrete, gypsum, & plaster products Sub-IndustryN/A Current SymbolOTCMKTS:YECO CUSIPN/A CIK1607741 Webwww.evbiologics.com Phone(518) 638-8192FaxN/AEmployees284Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,230,000Free Float6,006,000Market Cap$2.66 million OptionableNot Optionable Beta-0.19 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Daniel S. McKinney (Age 62)Founder, Chairman & CEO Mr. Monte FisherChief Financial OfficerMr. William BossungCorporate Finance Director & Corporate SecretaryKey CompetitorsContinental MaterialsNYSEAMERICAN:CUOMonarch CementOTCMKTS:MCEMWilliams Industrial Services GroupOTCMKTS:WLMSENGlobalNASDAQ:ENGWANG & LEE GROUPNASDAQ:WLGSView All Competitors YECO Stock Analysis - Frequently Asked Questions How have YECO shares performed this year? EV Biologics' stock was trading at $1.00 at the beginning of 2024. Since then, YECO stock has decreased by 74.0% and is now trading at $0.26. View the best growth stocks for 2024 here. How do I buy shares of EV Biologics? Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:YECO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EV Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EV Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.